Fetal fibronectin as a predictor of preterm birth in patients with symptoms: A multicenter trial
Peaceman AM, Andrews WW, Thorp JM, et al: Fetal fibronectin as a predictor of preterm birth in patients with symptoms: A multicenter trial. Am J Obstet Gynecol 1997;177:13-18
Fetal fibronectin in cervical and vaginal secretions defines a patient population at high risk for preterm delivery
Lockwood CJ, Senyei AE, Dische MR, et al: Fetal fibronectin in cervical and vaginal secretions defines a patient population at high risk for preterm delivery. N Engl J Med 1991;325:669-674
Fetal fibronectin as a predictor of preterm birth in actual clinical practice
Lopez RL, Francis JA, Garite TJ, et al: Fetal fibronectin as a predictor of preterm birth in actual clinical practice. Am J Obstet Gynecol 2000;182:1103-1106
Cervicovaginal fetal fibronectin testing in threatened preterm labour: Translating research findings into clinical practice
Chuileannain FN, Bell R, Brennecke S: Cervicovaginal fetal fibronectin testing in threatened preterm labour: Translating research findings into clinical practice. Aust N Z J Obstet Gynaecol 1998;38:399-402
Prospective randomized controlled trial of fetal fibronectin on preterm labor management in a tertiary care center
Lowe MP, Zimmerman B, Hansen W: Prospective randomized controlled trial of fetal fibronectin on preterm labor management in a tertiary care center. Am J Obstet Gynecol 2004;190:358-362
Cervicovaginal fetal fibronectin as a marker for preterm delivery: A meta-analysis
Leitich H, Egarter C, Kaider A, et al: Cervicovaginal fetal fibronectin as a marker for preterm delivery: A meta-analysis. Am J Obstet Gynecol 1999;180:1169-1176